NorthRock Partners LLC Boosts Stock Holdings in HCA Healthcare, Inc. $HCA

NorthRock Partners LLC increased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 4.1% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,234 shares of the company’s stock after purchasing an additional 89 shares during the quarter. NorthRock Partners LLC’s holdings in HCA Healthcare were worth $856,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Cheviot Value Management LLC purchased a new stake in HCA Healthcare in the first quarter worth approximately $26,000. Saudi Central Bank bought a new position in HCA Healthcare in the first quarter worth approximately $26,000. WPG Advisers LLC bought a new position in HCA Healthcare in the first quarter worth approximately $27,000. Ameriflex Group Inc. bought a new position in HCA Healthcare in the second quarter worth approximately $27,000. Finally, Chung Wu Investment Group LLC bought a new position in HCA Healthcare in the second quarter worth approximately $27,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on HCA shares. Wells Fargo & Company raised their price objective on shares of HCA Healthcare from $375.00 to $412.00 and gave the company an “equal weight” rating in a research report on Tuesday, October 7th. Bank of America raised their price objective on shares of HCA Healthcare from $375.00 to $410.00 and gave the company a “neutral” rating in a research report on Wednesday, September 10th. Cantor Fitzgerald restated an “overweight” rating and set a $444.00 price objective on shares of HCA Healthcare in a research report on Tuesday, October 7th. The Goldman Sachs Group started coverage on shares of HCA Healthcare in a report on Tuesday. They issued a “buy” rating and a $470.00 price target on the stock. Finally, Truist Financial set a $460.00 price target on shares of HCA Healthcare in a report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $431.07.

HCA Healthcare Trading Up 1.9%

HCA stock opened at $418.34 on Wednesday. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $439.01. The company has a 50-day moving average price of $407.16 and a 200 day moving average price of $376.85. The stock has a market cap of $97.89 billion, a PE ratio of 17.58, a P/E/G ratio of 1.29 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm had revenue of $18.61 billion during the quarter, compared to analysts’ expectations of $18.49 billion. During the same period in the previous year, the company earned $5.50 EPS. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare’s payout ratio is 12.11%.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.